Varanasi Ramani 4
4 · RXI PHARMACEUTICALS CORP · Filed Jul 21, 2010
Insider Transaction Report
Form 4
Varanasi Ramani
VP, Business Development
Transactions
- Award
Common Stock
2010-07-19$2.04/sh+5,600$11,424→ 11,158 total - Sale
Common Stock
2010-07-19$2.05/sh−5,000$10,266→ 5,558 total
Footnotes (1)
- [F1]The sale price reported in this Form 4 was between the range of $2.05 per share and $2.05432 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.